Weifa ASA – Strategy, SWOT and Corporate Finance Report

Weifa ASA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering products for pain relief; treatment of cough and colds; dermatology; Nutraceuticals; dietary supplements; and wound treatment among others. Its research and development activities focus on prescription drug products, OTC products and nutraceuticals. It offers products to consumers, customers and professional partners. The company has operational presence in Denmark, Iceland, Sweden and Finland. Weifa is headquartered in Oslo, Norway.

Scope

Detailed information on Weifa ASA required for business and competitor intelligence needs

A study of the major internal and external factors affecting Weifa ASA in the form of a SWOT analysis

An in-depth view of the business model of Weifa ASA including a breakdown and examination of key business segments

News about Weifa ASA, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Weifa ASA and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Weifa ASA as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Weifa ASAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Serodus ASA

Saipem Norge AS

Novartis Oncology

Lytix Biopharma AS

Halliburton AS

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 - About the Company 5

Weifa ASA - Key Facts 5

Weifa ASA - Key Employees 6

Weifa ASA - Key Employee Biographies 7

Weifa ASA - Major Products and Services 8

Weifa ASA - History 9

Weifa ASA - Company Statement 11

Weifa ASA - Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2 Company Analysis 13

Weifa ASA - Business Description 13

Weifa ASA - Corporate Strategy 14

Weifa ASA - SWOT Analysis 15

SWOT Analysis - Overview 15

Weifa ASA - Strengths 15

Weifa ASA - Weaknesses 16

Weifa ASA - Opportunities 17

Weifa ASA - Threats 18

Weifa ASA - Key Competitors 19

Section 3 Company Financial Ratios 20

Financial Ratios - Capital Market Ratios 20

Financial Ratios - Annual Ratios 21

Performance Chart 24

Financial Performance 24

Financial Ratios - Interim Ratios 25

Financial Ratios - Ratio Charts 26

Section 4 Company’s Lifesciences, Oil & Gas Financial Deals and Alliances 27

Weifa ASA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Weifa ASA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Weifa ASA, Recent Deals Summary 29

Section 5 Company’s Recent Developments 30

Apr 27, 2017: Weifa: Record First-Quarter Revenues Driven by Organic Growth 30

Oct 25, 2016: Weifa: Record Third-Quarter Revenues and Growth for all Main Categories 31

Oct 11, 2016: Weifa ASA to launch Ibux 200 mg soft capsules to strengthen its pain relief portfolio 32

Sep 14, 2016: Weifa to launch Solvivo - a new OTC product for sore throat in Norway 33

Aug 25, 2016: Weifa: Second Quarter 2016 Results 34

Jun 06, 2016: Weifa: Distribution agreement in Finland for unique pain products 35

Apr 26, 2016: Weifa: Record first-quarter revenues and proposed dividend 36

Section 6 Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41

List of Tables

List of Tables

Weifa ASA, Key Facts 5

Weifa ASA, Key Employees 6

Weifa ASA, Key Employee Biographies 7

Weifa ASA, Major Products and Services 8

Weifa ASA, History 9

Weifa ASA, Subsidiaries 12

Weifa ASA, Key Competitors 19

Weifa ASA, Ratios based on current share price 20

Weifa ASA, Annual Ratios 21

Weifa ASA, Annual Ratios (Cont…1) 22

Weifa ASA, Annual Ratios (Cont…2) 23

Weifa ASA, Interim Ratios 25

Weifa ASA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Weifa ASA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Weifa ASA, Recent Deals Summary 29

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

List of Figures

List of Figures

Weifa ASA, Performance Chart (2012 – 2016) 24

Weifa ASA, Ratio Charts 26

Weifa ASA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Weifa ASA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 28

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports